Page last updated: 2024-09-05

enzastaurin and torin 1

enzastaurin has been researched along with torin 1 in 1 studies

Compound Research Comparison

Studies
(enzastaurin)
Trials
(enzastaurin)
Recent Studies (post-2010)
(enzastaurin)
Studies
(torin 1)
Trials
(torin 1)
Recent Studies (post-2010) (torin 1)
188529919017

Protein Interaction Comparison

ProteinTaxonomyenzastaurin (IC50)torin 1 (IC50)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformHomo sapiens (human)0.564
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alphaHomo sapiens (human)0.176
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit betaHomo sapiens (human)0.549
Phosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)0.407
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)0.25
Serine/threonine-protein kinase mTORHomo sapiens (human)0.0042
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)0.171
DNA-dependent protein kinase catalytic subunitHomo sapiens (human)0.0063
Rapamycin-insensitive companion of mTORHomo sapiens (human)0.01
Regulatory-associated protein of mTORHomo sapiens (human)0.002
Phosphatidylinositol 3-kinase catalytic subunit type 3Homo sapiens (human)0.533
Target of rapamycin complex 2 subunit MAPKAP1Homo sapiens (human)0.01
Target of rapamycin complex subunit LST8Homo sapiens (human)0.006
Serine/threonine-protein kinase mTOR Mus musculus (house mouse)0.002
Phosphatidylinositol 4-kinase betaHomo sapiens (human)6.68

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1

Other Studies

1 other study(ies) available for enzastaurin and torin 1

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013